Daniel Friedberg, the former top lawyer for Sam Bankman-Fried's FTX, has reportedly begun cooperating with U.S. prosecutors as they investigate the cryptocurrency firm's collapse.
Kineta, Inc. (NASDAQ:KA) (the "Company" or "Kineta"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it